Invention Grant
- Patent Title: Nuclease-mediated regulation of gene expression
-
Application No.: US14540729Application Date: 2014-11-13
-
Publication No.: US11021696B2Publication Date: 2021-06-01
- Inventor: Stuart H. Orkin , Andreas Reik , Fyodor Urnov
- Applicant: Children's Medical Center Corporation , Sangamo Therapeutics, Inc.
- Applicant Address: US MA Boston; US CA Brisbane
- Assignee: Children's Medical Center Corporation,Sangamo Therapeutics, Inc.
- Current Assignee: Children's Medical Center Corporation,Sangamo Therapeutics, Inc.
- Current Assignee Address: US MA Boston; US CA Brisbane
- Agency: Lathrap GPM LLP
- Agent James H. Velema, Esq.
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/04 ; C12N15/63 ; C12N9/22 ; C12N15/85 ; A61K35/12 ; C12N15/113 ; C07K14/47 ; A61K38/46 ; A61K35/28 ; A01K67/00
Abstract:
The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic cell.
Public/Granted literature
- US20150132269A1 NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION Public/Granted day:2015-05-14
Information query
